Developing Small-Molecule Drugs for Epigenetic Treatments of Psychiatric Disorders

Time: 2:45 pm
day: Day One


  • Rationalizing the use of small-molecule compounds to target metabolicepigenetic pathways in the brain
  • Blocking a metabolic enzyme controls the epigenetic encoding of maladaptive memory
  • Preclinical models to develop epigenetic therapeutics for neuropsychiatric disorders